Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · Real-Time Price · USD
2.850
-0.020 (-0.70%)
Jan 17, 2025, 4:00 PM EST - Market closed
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $3.45 million as of January 17, 2025. Its market cap has decreased by -39.92% in one year.
Market Cap
3.45M
Enterprise Value
2.16M
1-Year Change
-39.92%
Ranking
Category
Stock Price
$2.85
Market Cap Chart
Since the IPO on December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from $32.74M to $3.45M, a decrease of -89.48%. That is a compound annual growth rate of -66.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 3.45M | -6.56% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -45.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |